Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway

Molecular Metabolism

Volumn 6, Issue 6, 2017, Pages 503-511

  Yusta, Bernardo ^c   Matthews, Dianne ^c   Flock, Grace B ^c   Ussher, John R ^c   Lavoie, Brigitte ^a   Mawe, Gary M ^a   Drucker, Daniel J ^b,c  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Bile acids; Enteroendocrine; Gallbladder; GLP 1; GLP 2; Glucagon like peptide; TGR5

Indexed keywords

CHOLECYSTOKININ; EXENDIN 4; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 2; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; HEXAMETHONIUM; LITHOCHOLIC ACID; N(G) NITROARGININE METHYL ESTER; PROPRANOLOL; TAUROCHOLIC ACID; TETRODOTOXIN; TGR5 PROTEIN; UNCLASSIFIED DRUG; GASTROINTESTINAL AGENT; GPBAR1 PROTEIN, MOUSE; PEPTIDE; TEDUGLUTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BARIATRIC SURGERY; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; EX VIVO STUDY; FEEDBACK SYSTEM; GALLBLADDER; HEPATIC BILE FLOW; INTRAHEPATIC BILE DUCT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MOUSE; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; C57BL MOUSE; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY;

ANIMALS; GALLBLADDER; GASTROINTESTINAL AGENTS; GLUCAGON-LIKE PEPTIDE-2 RECEPTOR; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; PEPTIDES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85017188305     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2017.03.006     Document Type: Article

References (38)

1. Li, T., Holmstrom, S.R., Kir, S., Umetani, M., Schmidt, D.R., Kliewer, S.A., et al. The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. Molecular Endocrinology 25:6 (2011), 1066–1071.
2. Lavoie, B., Balemba, O.B., Godfrey, C., Watson, C.A., Vassileva, G., Corvera, C.U., et al. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. The Journal of Physiology 588:Pt 17 (2010), 3295–3305.
3. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C.L., McDonald, J.G., et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metabolism 2:4 (2005), 217–225.
4. Choi, M., Moschetta, A., Bookout, A.L., Peng, L., Umetani, M., Holmstrom, S.R., et al. Identification of a hormonal basis for gallbladder filling. Nature Medicine 12:11 (2006), 1253–1255.
5. van Nierop, F.S., Scheltema, M.J., Eggink, H.M., Pols, T.W., Sonne, D.P., et al. Clinical relevance of the bile acid receptor TGR5 in metabolism. The Lancet Diabetes & Endocrinology 5:3 (2017), 224–233.
6. Marso, S.P., Daniels, G.H., Brown-Frandsen, K., Kristensen, P., Mann, J.F.E., Nauck, M.A., et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. The New England Journal of Medicine, 2016, 10.1056/NEJMoa1603827(0) [null].
7. Jeppesen, P.B., Pertkiewicz, M., Messing, B., Iyer, K., Seidner, D.L., O'Keefe, S.J., et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 143:6 (2012), 1473–1481.
8. Drucker, D.J., Yusta, B., Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annual Review of Physiology, 2014, 76561–76583.
9. Vassileva, G., Golovko, A., Markowitz, L., Abbondanzo, S.J., Zeng, M., Yang, S., et al. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochemical Journal 398:3 (2006), 423–430.
10. Lee, S.-J., Lee, J., Li, K.K., Holland, D., Maughan, H., Guttman, D.S., et al. Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis. Endocrinology 153:3 (2012), 1141–1151.
11. Gozes, I., McCune, S.K., Jacobson, L., Warren, D., Moody, T.W., Fridkin, M., et al. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. Journal of Pharmacology and Experimental Therapeutics 257:3 (1991), 959–966.
12. Woods, S.E., Leonard, M.R., Hayden, J.A., Brophy, M.B., Bernert, K.R., Lavoie, B., et al. Impaired cholecystokinin-induced gallbladder emptying incriminated in spontaneous “black” pigment gallstone formation in germfree Swiss Webster mice. American Journal of Physiology–Gastrointestinal and Liver Physiology 308:4 (2015), G335–G349.
13. Dodds, W.J., Groh, W.J., Darweesh, R.M., Lawson, T.L., Kishk, S.M., Kern, M.K., Sonographic measurement of gallbladder volume. American Journal of Roentgenology 145:5 (1985), 1009–1011.
14. Kim, M., Platt, M., Shibasaki, T., Quaggin, S., Backx, P.H., Seino, S., et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nature Medicine 19:5 (2013), 567–575.
15. Yusta, B., Baggio, L.L., Estall, J.E., Koehler, J.A., Holland, D.P., Li, H., et al. GLP-1 receptor activation improves β-cell function and survival following induction of endoplasmic reticulum stress. Cell Metabolism 4:5 (2006), 391–406.
16. Tsai, C.-H., Hill, M., Drucker, D.J., Biological determinants of intestinotrophic properties of GLP-2 in vivo. American Journal of Physiology 272 (1997), G662–G668.
17. Munroe, D.G., Gupta, A.K., Kooshesh, F., Vyas, T.B., Rizkalla, G., Wang, H., et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proceedings of the National Academy of Sciences of the United States of America 96:4 (1999), 1569–1573.
18. Yusta, B., Huang, L., Munroe, D., Wolff, G., Fantaske, R., Sharma, S., et al. Enteroendocrine localization of GLP-2 receptor expression. Gastroenterology 119:3 (2000), 744–755.
19. Gu, X., Li, B., Jiang, M., Fang, M., Ji, J., Wang, A., et al. RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma. Oncotarget 6:24 (2015), 20661–20671.
20. Yusta, B., Holland, D., Koehler, J.A., Maziarz, M., Estall, J.L., Higgins, R., et al. ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut. Gastroenterology 173:3 (2009), 986–996.
21. Jain, A.K., Stoll, B., Burrin, D.G., Holst, J.J., Moore, D.D., Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs. American Journal of Physiology–Gastrointestinal and Liver Physiology 302:2 (2012), G218–G224.
22. de Diego-Cabero, N., Mereu, A., Menoyo, D., Holst, J.J., Ipharraguerre, I.R., Bile acid mediated effects on gut integrity and performance of early-weaned piglets. BMC Veterinary Research, 2015, 11111.
23. Hansen, M., Scheltema, M.J., Sonne, D.P., Hansen, J.S., Sperling, M., Rehfeld, J.F., et al. Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion. Diabetes, Obesity and Metabolism 18:6 (2016), 571–580.
24. Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metabolism 10:3 (2009), 167–177.
25. Parker, H., Wallis, K., le Roux, C., Wong, K., Reimann, F., Gribble, F., Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. British Journal of Pharmacology 165:2 (2012), 414–423.
26. Guan, X., Stoll, B., Lu, X., Tappenden, K.A., Holst, J.J., Hartmann, B., et al. GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets. Gastroenterology 125:1 (2003), 136–147.
27. Mawe, G.M., Nerves and hormones interact to control gallbladder function. News in Physiological Sciences, 1998, 1384–1390.
28. Sonobe, K., Sakai, T., Satoh, M., Haga, N., Itoh, Z., Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors in the vagal pathway and gallbladder in the dog. Regulatory Peptides 60:1 (1995), 33–46.
29. Sigalet, D.L., Wallace, L.E., Holst, J.J., Martin, G.R., Kaji, T., Tanaka, H., et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. American Journal of Physiology-Gastrointestinal and Liver Physiology 293:1 (2007), G211–G221.
30. Ryan, J., Cohen, S., Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure. Gastroenterology 73:4 Pt 1 (1977), 870–872.
31. Mourelle, M., Guarner, F., Molero, X., Moncada, S., Malagelada, J.R., Regulation of gall bladder motility by the arginine-nitric oxide pathway in Guinea pigs. Gut 34:7 (1993), 911–915.
32. Schjoldager, B., Shaw, M.J., Powers, S.P., Schmalz, P.F., Szurszewski, J., Miller, L.J., Bovine gallbladder muscularis: source of a myogenic receptor for cholecystokinin. American Journal of Physiology 254:3 Pt 1 (1988), G294–G299.
33. Keller, J., Trautmann, M.E., Haber, H., Tham, L.S., Hunt, T., Mace, K., et al. Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects. Regulatory Peptides 179:1–3 (2012), 77–83.
34. Smits, M.M., Tonneijck, L., Muskiet, M.H., Hoekstra, T., Kramer, M.H., Diamant, M., et al. Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients. Diabetes, Obesity and Metabolism 18:12 (2016), 1217–1225.
35. Grover, B.T., Kothari, S.N., Biliary issues in the bariatric population. Surgical Clinics of North America 94:2 (2014), 413–425.
36. Pineda, O., Maydon, H.G., Amado, M., Sepulveda, E.M., Guilbert, L., Espinosa, O., et al. A prospective study of the conservative management of asymptomatic preoperative and postoperative gallbladder disease in bariatric surgery. Obesity Surgery 27:1 (2017), 148–153.
37. Brighton, C.A., Rievaj, J., Kuhre, R.E., Glass, L.L., Schoonjans, K., Holst, J.J., et al. Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors. Endocrinology 156:11 (2015), 3961–3970.
38. Cao, H., Chen, Z.X., Wang, K., Ning, M.M., Zou, Q.A., Feng, Y., et al. Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect. Scientific Reports, 2016, 628676.